[go: up one dir, main page]

WO2012105804A2 - Probiotiques pour la lutte biologique contre saprolegnia sp. - Google Patents

Probiotiques pour la lutte biologique contre saprolegnia sp. Download PDF

Info

Publication number
WO2012105804A2
WO2012105804A2 PCT/KR2012/000758 KR2012000758W WO2012105804A2 WO 2012105804 A2 WO2012105804 A2 WO 2012105804A2 KR 2012000758 W KR2012000758 W KR 2012000758W WO 2012105804 A2 WO2012105804 A2 WO 2012105804A2
Authority
WO
WIPO (PCT)
Prior art keywords
strain
bacillus
culture broth
concentrate
dry product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2012/000758
Other languages
English (en)
Other versions
WO2012105804A3 (fr
Inventor
Si Yong Yang
Seo Hyung WOO
In Hye Kang
Hyo Seel SEO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CJ CheilJedang Corp
Original Assignee
CJ CheilJedang Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CJ CheilJedang Corp filed Critical CJ CheilJedang Corp
Priority to PH1/2013/501608A priority Critical patent/PH12013501608B1/en
Priority to RU2013138150/10A priority patent/RU2555549C2/ru
Publication of WO2012105804A2 publication Critical patent/WO2012105804A2/fr
Publication of WO2012105804A3 publication Critical patent/WO2012105804A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/20—Bacteria; Substances produced thereby or obtained therefrom
    • A01N63/22—Bacillus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F3/00—Biological treatment of water, waste water, or sewage
    • C02F3/34—Biological treatment of water, waste water, or sewage characterised by the microorganisms used
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07—Bacillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/832—Bacillus

Definitions

  • the present invention relates to probiotics for biological control against Saprolegnia sp., and in particular, to a newly isolated bacillus strain that inhibits the growth of a pathogenic fungus, Saprolegnia sp. and produces siderophores; a culture broth obtained by culturing the strain, a concentrate thereof, or a dry product thereof; a probiotic composition, a feed additive, an antimicrobial agent, an antifungal agent, or a water quality improving agent comprising the strain, the culture broth thereof, the concentrate thereof, or the dry product thereof; a method for culturing fish or crustaceans using the strain, the culture broth thereof, the concentrate thereof, or the dry product thereof; a method for preventing saprolegniosis in animals by addition of the strain, the culture broth thereof, the concentrate thereof, or the dry product thereof; and a method for improving water quality by treatment with the strain, the culture broth thereof, the concentrate thereof, or the dry product thereof.
  • the occurrence of diseases in fish farms is caused by infected fish or pathogens transmitted from the marine environment near aquaculture farms, and also caused by a supply of contaminated fish feed or unsanitary conditions in the fish farms.
  • Infectious diseases of fish are divided to fungal, bacterial, and viral infections.
  • a representative fungal infection is caused by Saprolegnia sp. (Diagnosis of Fish Diseases and Treatment Measures, The Ministry of Maritime Affairs and Fisheries, 2001).
  • Saprolegnia sp. is ubiquitous in freshwater ecosystems and is the main genus of water molds responsible for significant fungal infections of freshwater fish. In fish, Saprolegnia sp.
  • Saprolegnia sp. causes primary infections, but in most cases, occurs as a secondary pathogen, following the primary damage to the fish integument caused by parasites such as viruses and bacteria (Aquatic fungi and fish production in Egypt, II-in vivo studies).
  • 6160023 discloses the use of bronopol in the treatment of various diseases of aquatic organisms, including fungal infections, protozoan infections, and bacterial gill disease, and a method of disinfecting fish tanks and/or equipment using bronopol.
  • Korean Patent No. 0782500 discloses a therapeutic agent for fungal infection of fish, comprising an extract of sweet flag.(acorus calamus) as an active ingredient.
  • probiotics as an immune enhancer
  • Probiotic use was popularized by R. Fuller in 1989, and was formulated as a live microbial feed supplement, which beneficially affects the host by improving its intestinal microbial balance.
  • bacteria such as Lactobacillus, Enterococcus, Bifidobacterium, and Bacillus
  • yeasts such as Saccharomyces
  • fungi such as Aspergillus
  • GRAS Generally Recognized As Safe
  • Probiotics are microorganisms approved to have efficacy of improving productivity in livestock.
  • Probiotics are characterized by non-pathogenicity, easy in vitro proliferation, rapid growth in the body, and resistance to acid and bile. In addition, their activity should not be inhibited by feed ingredients, their effects should be maintained at room temperature, and they should be easily blended with feed for convenience.
  • Probiotics have the efficacies of competing with pathogenic bacteria which cause enteric diseases to prevent their strong adhesion to the intestinal epithelium, and rapidly recovering the intestinal microbial flora altered as a result of antibiotic treatment. Further, probiotics prevent infection of pathogenic microorganisms and inhibit their proliferation, promote the proliferation of intestinal microbial flora by supporting optimal conditions, produce lactic acid or acetic acid constituting intestinal organic acids, and lower the pH in the intestine to prevent proliferation of harmful, pathogenic bacteria. Therefore, the feeding of probiotics having the above multiple actions maintains intestinal microbial flora and enhances productivity in livestock. In aquaculture, probiotics are also added to fish feed or additionally to water.
  • probiotics used for biological control in aquaculture are exemplified by beneficial bacteria such as Lactobacillus, Enterococcus, and Bacillus.
  • Bacillus is a Gram-Positive, rod-shaped, endospore-forming bacterium, and has a distinctive morphology among the strains used as probiotics.
  • Strains such as Bacillus subtilis (B. subtilis), Bacillus cereus (B. cereus), Bacillus coagulans (B. coagulans), Bacillus clausii (B.
  • Bacillus megaterium B. megaterium
  • Bacillus licheniformis B. licheniformis
  • Bacillus is more excellent in heat resistance than lactobacillus which does not form endospores. Further, Bacillus is able to survive at the low pH of the gastric barrier, and thus most of ingested bacteria reach the small intestine intact (Barbosa, T.M. et al. Appl. Environ. Microbiol. 71(2005)968-978; Spinosa, M. R. et al. Res. Microbiol. 151(2000):61-368).
  • Bacillus is used in humans as dietary supplements and in animals as growth promoters, and also used to promote growth and disease resistance of fish or shrimp in aquaculture, and improves water quality and growth rate of shrimp, and reduces pathogenic vibrios (Dalmin, G. et al. Indian J. Exp. Biol 39(2001) 939-942; Wang, Y.B. et al. Fish. Sci. 71(2005) 1034-1039).
  • siderophore is a kind of antibiotic produced by microorganisms including pathogenic bacteria that compete with other microorganisms for rapid growth and proliferation under a given environment.
  • Siderophores bind with iron ions (Fe3+), and are then transported into the cells through a high-affinity iron-transport system, and the iron ions (Fe3+) support the growth of microorganisms.
  • Microorganisms produce siderophores because of competition for iron ions (Fe3+), and a high production of siderophores inhibits the growth of other microorganisms.
  • siderophore-producing bacteria have been actively studied to be used as a potential biological control agent.
  • 037043 discloses a new antagonistic strain of Pseudomonas fluorescens LS20 producing siderophore, a method for inhibiting the growth of a plant pathogenic rhizobacterium, Fusarium solani using Pseudomonas fluorescens LS20, and a method for treating diseases caused by plant pathogenic fungi using siderophores.
  • Korean Patent No. 0747700 discloses siderophore-producing Bacillus subtilis and a composition for the control of Phytophtora capsici or Fusarium oxysporum including siderophores produced thereby as an active ingredient.
  • the present inventors have isolated probiotics from a natural source, in which the probiotics have excellent antimicrobial activity against pathogenic bacteria in the aquaculture of fish and shrimp and excellent productivity of digestive enzymes, and they examined the morphological, biochemical and genetic characteristics thereof. As a result, they found that the probiotics are Bacillus having excellent heat-resistance, and the bacillus is excellent in siderophore productivity and inhibition of an aquatic fungus, Saprolegnia sp.
  • the present inventors found that the newly isolated Bacillus sp. inhibits the growth of an aquatic fungus, Saprolegnia sp., and has excellent siderophore productivity to compete with pathogenic bacteria for iron capture, and thus can be used as a probiotic composition for the aquaculture of fish and crustaceans, thereby completing the present invention.
  • An object of the present invention is to provide a newly isolated Bacillus strain that inhibits the growth of Saprolegnia sp. and produces siderophores.
  • Another object of the present invention is to provide a culture broth obtained by culturing the strain, a concentrate thereof, or a dry product thereof.
  • Still another object of the present invention is to provide a probiotic composition comprising the strain, the culture broth thereof, the concentrate thereof, or the dry product thereof.
  • Still another object of the present invention is to provide a feed additive comprising the strain, the culture broth thereof, the concentrate thereof, or the dry product thereof.
  • Still another object of the present invention is to provide a method for culturing fish or crustaceans using the strain, the culture broth thereof, the concentrate thereof, or the dry product thereof.
  • Still another object of the present invention is to provide an antimicrobial agent or an antifungal agent comprising the strain, the culture broth thereof, the concentrate thereof, or the dry product thereof.
  • Still another object of the present invention is to provide a method for preventing saprolegniosis by addition of the strain, the culture broth thereof, the concentrate thereof, or the dry product thereof.
  • Still another object of the present invention is to provide an water quality improving agent comprising the strain, the culture broth thereof, the concentrate thereof, or the dry product thereof.
  • Still another object of the present invention is to provide a method for improving water quality by treatment with the strain, the culture broth thereof, the concentrate thereof, or the dry product thereof.
  • the newly isolated Bacillus sp. CJP-14 of the present invention shows excellent antifungal effect on an aquatic fungus, Saprolegnia sp. and also produces siderophores. Therefore, it can be widely applied to various products capable of controlling fungal infections including Saprolegnia sp. infection and bacterial infection, such as feed additives for aquaculture, probiotic compositions, and water quality-improving agents.
  • FIG. 1 is a photograph showing that the Bacillus sp. CJP-14 of the present invention inhibited the growth of an aquatic fungus Saprolegnia sp.;
  • FIG. 2 is a photograph showing the antimicrobial activity by siderophore formation of the Bacillus sp. CJP-14 of the present invention on the fish pathogens, Vibrio harveyi (VH1, VH2, VH3), Vibrio cholerae (VC), Vibrio vulnificus (VV), and Aeromonas salmonicida (AS) in CAS medium;
  • Vibrio harveyi VH1, VH2, VH3
  • Vibrio cholerae VC
  • VV Vibrio vulnificus
  • AS Aeromonas salmonicida
  • FIG. 3 is a photograph showing the presence of hemolysis of the Bacillus sp. CJP-14 of the present invention.
  • FIG. 4 is a photograph showing the nitrous acid utilization of the Bacillus sp. CJP-14 of the present invention.
  • the present invention provides a newly isolated Bacillus sp. CJP-14 (KCCM11143P).
  • the strain is able to produce siderophores and also inhibit the growth of Saprolegnia sp.
  • seawater-derived samples were collected in the shrimp farms around Ganghwa Island, and cultured in a BHI solid media supplemented with 3% sodium chloride. Then, the colonies were observed for grouping, and strains were isolated.
  • strains showing excellent antibacterial activity on the representative pathogenic bacteria attacking the cultured fish including Aeromonas salmonicida, Vibrio harveyi, Vibrio anguillarum, Edwardsiella tarda, Streptococcus iniae, and Vibrio haemolyticus, were selected by primary screening.
  • strains having excellent antibacterial activity strains having excellent activity of digestive enzymes such as protease, cellulase, amylase, and lipase were selected by secondary screening.
  • Bacillus sp. CJP-14 having excellent inhibitory effect on Saprolegnia sp. which is a pathogenic fungus in freshwater fish having excellent siderophore productivity to capture iron ions (Fe3+), thereby showing competitive antagonistic action on the growth of other pathogenic bacteria.
  • the Bacillus sp. CJP-14 has a Gram-positive rod-shaped morphology, and showed 99% homology with Bacillus sp. W30 in the result of 16s rDNA base sequence analysis.
  • the 16s rDNA base sequence of the known siderophore-producing Bacillus subtilis AH18 shows 98% homology with that of Bacillus subtilis strain CICC 10088 (see Korean Patent No. 0717700), it can be seen that the strain of the present invention is a novel strain that has never been known.
  • the strain of the present invention is able to produce siderophore as well as cellulase, protease, amylase, and lipase, whereas Bacillus subtilis AH18 is able to produce cellulose and auxin in addition to siderophores, indicating that the strain of the present invention is a novel strain that has never been known.
  • the present inventors deposited the newly isolated Bacillus sp. CJP-14 at the Korean Federation of Culture Collection (in Korean Culture Center of Microorganisms, 361-221, Yurim B/D 3F, Hongje-1-dong, Seodaemun-gu, Seoul) on DEC. 14, 2010 as "Bacillus sp. CJP-14" (KCCM11143P).
  • the present invention provides a culture broth obtained by culturing the newly isolated Bacillus sp. strain, a concentrate thereof, or a dry product thereof.
  • the culture broth of the present invention means a media where the newly isolated Bacillus sp. strain CJP-14 was cultured, and preferably a culture medium including the strain.
  • the culture medium means a medium including nutrients that are required for culturing animal cells, plant cells or bacteria
  • the culture broth means a liquid medium where a strain is inoculated and cultured.
  • the culture broth may be a medium including the strain, or a culture filtrate that is prepared by removing the strain from the culture broth where the strain was inoculated and cultured.
  • the concentrate of the culture broth means those prepared by concentrating the culture broth, and the dry product of the culture broth means those prepared by removing water from the culture broth.
  • the drying method may include air drying, natural drying, spray drying, and freeze drying, but is not limited thereto.
  • the present invention provides a probiotic composition
  • a probiotic composition comprising the newly isolated Bacillus sp. or the culture broth thereof, the concentrate thereof, or the dry product thereof as an active ingredient, and a pharmaceutically acceptable carrier.
  • the term "pharmaceutically acceptable carrier” refers to a carrier or diluent that does not cause significant irritation to an organism and does not abrogate the biological activity and properties of the administered compound.
  • a pharmaceutically acceptable carrier which is sterile and biocompatible may be used such as saline, sterile water, buffered saline, albumin infusion solution, dextrose solution, maltodextrin solution, glycerol, and mixtures of one or more thereof. If necessary, other conventional additives may be added such as antioxidants, buffers, bacteriostatic agents, and the like.
  • diluents such as aqueous solutions, suspensions, and emulsions, or pills, capsules, granules, or tablets.
  • the newly isolated Bacillus sp. that is included as an active ingredient in the probiotics of the present invention lives in the gastrointestinal tract of cultured fish or crustaceans to inhibit harmful bacteria and proliferation of pathogenic bacteria.
  • beneficial digestive enzymes produced by the strain facilitate absorption and utility of nutrients to improve a feed conversion rate.
  • composition of the present invention includes 5 x 10 4 to 5 x 10 10 CFU/ml and preferably 1 x 10 6 to 1 x 10 9 CFU/ml of the Bacillus CJP-14.
  • the composition of the present invention may be prepared in oral dosage forms, and examples of the oral dosage forms may include tablets, troches, lozenges, aqueous or emulsive suspensions, powder or granules, emulsions, hard or soft capsules, syrups, or elixirs.
  • a binder such as lactose, saccharose, sorbitol, mannitol, starch, amylopectin, cellulose or gelatin, an excipient such as dicalcium phosphate, a disintegrant such as corn starch or sweet potato starch, a lubricant such as magnesium stearate, calcium stearate, sodium stearylfumarate, or polyethylene glycol wax.
  • a liquid carrier such as a lipid may be further used in addition to the above-mentioned compounds.
  • the present invention provides a feed additive comprising the newly isolated Bacillus sp. strain or the culture broth thereof, the concentrate thereof or the dry product thereof.
  • the newly isolated Bacillus sp. CJP-14 may be prepared in the form of feed additive, and then added to feed. Alternatively, the newly isolated Bacillus sp. CJP-14 may be directly added during the feed preparation.
  • the Bacillus sp. CJP-14 in the feed of the present invention may be in a liquid or dry form, and preferably in a dry powdery form.
  • the drying method may include air drying, natural drying, spray drying, and freeze drying, but is not limited thereto.
  • CJP-14 of the present invention may be mixed in the powder form at a ratio of 0.05 to 10% by weight, and preferably 0.1% to 1% by weight, based on the feed weight.
  • the feed for aquaculture may further include common additives to improve the preservability, in addition to the Bacillus sp. CJP-14 of the present invention.
  • the feeds comprising the Bacillus sp. CJP-14 of the present invention may include plant-based feeds such as grains, nuts, food processing byproducts, algae, fibers, oil, starches, meals, and grain byproducts, and animal-based feeds such as proteins, inorganic substances, fat, minerals, single-cell proteins, zooplankton, and fish meals, but are not limited thereto.
  • plant-based feeds such as grains, nuts, food processing byproducts, algae, fibers, oil, starches, meals, and grain byproducts
  • animal-based feeds such as proteins, inorganic substances, fat, minerals, single-cell proteins, zooplankton, and fish meals, but are not limited thereto.
  • the probiotic composition comprising the Bacillus sp. CJP-14 include additives for preventing quality deterioration, such as binders, emulsifiers and preservatives, and additives for increasing utility, such as amino acids, vitamins, enzymes, flavorings, non-protein nitrogen, silicates, buffering agents, extracts, and oligosaccharides, but is not limited thereto.
  • the probiotic composition including the Bacillus sp. CJP-14 may further include feed premixes, but is not limited thereto.
  • the present invention provides a method for culturing fish or crustaceans, comprising the step of treating aquaculture farm of fish or crustaceans using the newly isolated Bacillus strain, the culture broth thereof, the concentrate thereof, or the dry product thereof.
  • the newly isolated Bacillus sp. CJP-14 of the present invention has a wide variety of antimicrobial activity and also competitive antagonistic action to inhibit the growth of other pathogenic bacteria.
  • the strain is used to prevent the diseases caused by the common pathogenic bacteria in aquaculture, thereby culturing fish or crustaceans with safety.
  • the present invention provides an antimicrobial agent or an antifungal agent comprising the newly isolated Bacillus strain, the culture broth thereof, the concentrate thereof, or the dry product thereof.
  • prevention is intended to encompass all actions for restraining or delaying disease progress through the administration of the composition.
  • the newly isolated Bacillus sp. CJP-14 of the present invention has antimicrobial activity against the above described 6 types of pathogenic bacteria in aquaculture, and produces siderophores to show an excellent iron-capturing ability.
  • the newly isolated Bacillus sp. CJP-14 of the present invention has competitive antagonistic action to inhibit the growth of other pathogenic bacteria.
  • the newly isolated Bacillus sp. CJP-14 is able to inhibit the growth of a pathogenic aquatic fungus, Saprolegnia sp.
  • the newly isolated Bacillus sp. is used to prevent the diseases caused by the above described pathogenic bacteria in aquaculture.
  • the present invention provides an agent for improving water quality, comprising the newly isolated Bacillus sp., the culture broth thereof, the concentrate thereof, or the dry product thereof.
  • the newly isolated Bacillus sp. CJP-14 of the present invention can be used to reduce the content of nitrous acid present in the aquaculture environment.
  • the newly isolated Bacillus sp. CJP-14 of the present invention may be separately prepared in the form of an agent for improving water quality, or the newly isolated Bacillus sp. CJP-14, the culture broth thereof, the concentrate thereof, or the dry product thereof may be directly sprayed.
  • the Bacillus sp. CJP-14 in the agent for improving water quality of the present invention may be in a liquid or dry form, and is preferably in a dry powdery form.
  • a carrier which is sterile and biocompatible may be used such as saline, sterile water, buffered saline, albumin infusion solution, dextrose solution, maltodextrin solution, glycerol, and mixtures of one or more thereof.
  • other conventional additives may be added such as antioxidants, buffers, bacteriostatic agents, and the like.
  • diluents, dispersants, surfactants, binders and lubricants may be additionally added to the composition to prepare injectable formulations such as aqueous solutions, suspensions, and emulsions, or pills, capsules, granules, or tablets.
  • the water quality of an aquaculture farm can be improved.
  • the agent for improving water quality may be added to the aquaculture farm before aquaculture or during aquaculture.
  • it is added to the aquaculture farm before aquaculture and left for a predetermined period. Consequently, the newly isolated Bacillus sp. CJP-14 of the present invention sufficiently produces siderophores to show an excellent iron-capturing ability, and thus inhibits the growth of other pathogenic bacteria and Saprolegnia sp.
  • the agent for improving water quality is added during aquaculture one or more times so as to prevent additional growth of Saprolegnia sp.
  • the present invention provides a method for improving water quality, comprising the step of treating water with the newly isolated Bacillus sp., the culture broth thereof, the concentrate thereof, or the dry product thereof.
  • the improved water can be used in an aquaculture farm, and may also be used as drinking water for livestock or humans.
  • the water treated with the newly isolated Bacillus sp., the culture broth thereof, the concentrate thereof, or the dry product thereof is preferably purified before use, and the step of purifying water is performed by a known method.
  • Example 1 Isolation of Bacillus sp. CJP-14
  • Example 1-1 Sample Acquisition and Strain Isolation
  • the present inventors collected seawater-derived samples in the shrimp farms that show low occurrence of domestic diseases and high productivity.
  • the collected samples were serially diluted and spread on a BHI agar (Difco, USA) supplemented with 3% sodium chloride, followed by cultivation at 37°C for 24 hours.
  • Grouping of the strains isolated from each sample were performed by colony observation, and the strains was selected.
  • the selected colonies were cultured in fresh medium three times for isolation.
  • the isolated strains were stored in a medium containing 20% glycerol at -70°C or lower.
  • Example 1-2 Selection of Strains Having High Antimicrobial and Antifungal Activities
  • test of antimicrobial activity against 6 types of bacteria including Aeromonas salmonicida, Vibrio harveyi, Vibrio anguillarum, Edwardsiella tarda, and Vibrio haemolyticus was performed.
  • VH Vibrio harveyi
  • VP Vibrio hemolyticus
  • VA Vibrio anguillarum.
  • Example 1-3 Selection of Strains Having High Enzymatic Activity
  • Example 1-3-1 Collection of Crude Enzyme Extract
  • the 20 types of the strains having antimicrobial activity were cultured in BHI medium for 8, 24, and 48 hours, respectively and their culture broth was collected, followed by centrifugation at 4°C and 13,000 rpm for 5 minutes. The final supernatant was used as a crude enzyme extract for the analysis of enzymatic activity, and media including each substrate for the following enzymes were used to determine the substrate degradation.
  • a YM (Difco, USA) medium supplemented with 2% skim milk (Sigma, USA) as a substrate was prepared. 3 ⁇ l of the collected crude enzyme extract was added to each substrate medium, and then reacted at 30°C for 2 hours. Enzyme activity was determined by the presence of the clear zone surrounding the crude enzyme extract, which is formed by substrate degradation.
  • a YM medium supplemented with 1% CMC (carboxyl methyl cellulose) as a substrate was prepared. 3 ⁇ l of the collected crude enzyme extract was added to each substrate medium, and then reacted at 30°C for 2 hours, followed by straining with a 0.2% congo red aqueous solution for 30 minutes and destaining with 1 M NaCl aqueous solution. Enzyme activity was determined by the presence of the clear zone surrounding the crude enzyme extract, which is formed by substrate degradation.
  • a YM medium supplemented with 1% soluble starch as a substrate was prepared. 3 ⁇ l of the collected crude enzyme extract was added to each substrate medium, and then reacted at 30°C for 2 hours, followed by straining with an aqueous solution containing 0.1% I2 and 2% KI. Enzyme activity was determined by the presence of the clear zone surrounding the crude enzyme extract, which is formed by substrate degradation.
  • a YM medium supplemented with 1% tricaptylin as a substrate was prepared. 3 ⁇ l of the collected crude enzyme extract was added to each substrate medium, and then reacted at 30°C for 2 hours. Then, enzyme activity was determined by the presence of the clear zone surrounding the crude enzyme extract, which is formed by substrate degradation.
  • the inhibitory effect on a pathogenic fungus Saprolegnia sp. in freshwater fish was examined in vitro using 4 candidate strains having excellent antimicrobial and antifungal activities, and complex enzyme productivity.
  • Saprolegnia sp. was cultured by stationary culture on a PDA (Difco, USA) solid medium at 30°C for 72 hours. Saprolegnia sp. cultured on the solid medium was cut into a size of 5 mm x 5 mm (width x length), and inoculated on the center of a fresh PDA solid medium, and cultured for 24 hours. Each 20 ⁇ l of the 4 candidate strains were placed on sterile paper discs, and then inoculated on the solid medium where Saprolegnia sp. was cultured, followed by cultivation at 30°C for 48 hours. As shown in Table 3, the presence of clear zone surrounding the 4 candidate strains was observed (FIG. 1).
  • the 4 candidate strains were cultured in BHI media at 37°C, 200 rpm for 8 hours. Each culture broth was serially diluted at a density of 10 8 CFU, 10 7 CFU, 10 6 CFU, 10 5 CFU, and 10 4 CFU, and added to each well of 24 well plates (Falcon, USA), and Saprolegnia sp. was added thereto at a density of 102 to a final volume of 1 ml. 0.5 ml of PDB liquid medium (Difco, USA) supplemented with 0.5 g/L peptone and 20 g/L yeast extract was added thereto, followed by cultivation at 25°C for 48 hours. Inhibition on fungal activity was evaluated by solidification, and two candidate strains inhibited the growth of Saprolegnia sp., as shown in the following Table 4.
  • CAS assay was performed. CAS medium was prepared as follows.
  • Table 5 CAS medium composition for evaluation of siderophore productivity Fe solution (1 mM FeCl3 ⁇ 6H2O in 10 mM HCl) 1.5 CAS solution (0.121 g CAS in 100 ml distilled water) 7.5 HDTMA (0.0219 g HDTMA in 50 ml distilled water) 50 pH 6.5 piperazine buffer(4.307g piperazine in 30 ml distilled water) 30 Distilled water 100(the rest)
  • Each of the 4 candidate strains was inoculated with 0.1% in the BHI liquid medium, and cultured at 37°C and 200 rpm for 18 hours.
  • each of pathogenic bacteria, Vibrio harveyi, Vibrio cholerae, Vibrio vulnificus, and Aeromonas salmonicida was inoculated with 0.1% in LB medium supplemented with 2% sodium chloride, and cultured at 30°C, 200 rpm for 18 hours. Each culture supernatant was filtered using a 0.45 ⁇ m filter, and the filtered culture supernatant was used to perform the experiment.
  • a hole with a diameter of 0.5 cm was made in the CAS agar, and each 50 ⁇ l of the filtered culture supernatant was inoculated in the hole, and reacted at 37°C for 8 hours. As shown in FIG. 2, an orange-colored clear zone surrounding the hole, which is formed upon utilization of iron, was observed.
  • the Bacillus sp. CJP-14 having most excellent siderophore productivity among the 4 candidate strains and above 4 types of pathogenic bacteria was finally selected (Table 6).
  • the CJP-14 strain showing excellent inhibitory effect on Saprolegnia sp. and excellent siderophore productivity was finally selected, identified, and analyzed. Identification of the strain was performed by physiological and biochemical methods and molecular systematic methods. The strain was found to have the morphological characteristic of Gram-positive rod-shaped bacterium. Analysis of the 16s rDNA sequence showed that the strain has 99% homology with Bacillus sp., indicating a novel microorganism. The base sequence of 16s rDNA of the isolated strain is represented by SEQ ID NO. 1.
  • the base sequence analysis was performed by amplification of 16s rDNA using a PCR premix (Bioneer, Korea) and universal primers 27F and 492R having the base sequence below.
  • the gene amplification was performed in a total reaction volume of 20 ⁇ l for total 30 cycles consisting of at 94°C for 1 minute, at 56°C for 1 minute, and at 72°C for 1 minute to analyze the base sequence of the amplified DNA.
  • the novel microorganism of the present invention that was identified by the above method was deposited at the Korean Federation of Culture Collection (in Korean Culture Center of Microorganisms, 361-221, Yurim B/D 3F, Hongje-1-dong, Seodaemun-gu, Seoul) on DEC. 14, 2010 as "Bacillus sp. CJP-14" (KCCM11143P).
  • ⁇ -Hemolysis is a complete lysis of red blood cells, which is caused by hydrolysis of phospholipid by phospholipase-producing bacteria.
  • the initial concentration of nitrous acid in the medium was approximately 10 mg.
  • consumption of nitrous acid was approximately 94% after cultivation for 30 hours (see FIG. 4).
  • Example 6 Efficacy on Freshwater Fish-Pathogenic Fungus, Saprolegnia sp.
  • the efficacy of Bacillus sp. CJP-14 having inhibitory effect on freshwater fish-pathogenic fungus, Saprolegnia sp. in vitro and having excellent siderophore productivity was evaluated.
  • the present inventors infected fertilized eggs of rainbow trout with Saprolegnia sp. in the presence of the Bacillus sp. CJP-14 of the present invention, and then the eyed rate (%) was examined.
  • Egg-eyed rate (%) (the number of eyed eggs / the number of used fertilized eggs) X 100
  • the eyed rate of the control group was 0.5%, and those of sodium chloride and formalin currently used as an antifungal agent were 52.3% and 19.5%, respectively.
  • Treatment with the Bacillus sp. CJP-14 of 1 x 10 8 CFU or higher showed more excellent efficacy than sodium chloride and formalin solution, indicating the inhibitory effect of the bacillus sp. CJP-14 of the present invention on the freshwater fish-pathogenic fungus, Saprolegnia sp.
  • the Bacillus sp. CJP-14 of the present invention In order to examine whether the Bacillus sp. CJP-14 of the present invention practically shows the probiotic action when it is added to feed and fish are fed with the feed, the Bacillus sp. CJP-14 of the present invention was mixed with feed, and juvenile flounder was fed with the mixed feed for 8 weeks, so as to determine the rate of weight gain, daily growth rate, feed conversion ratio, protein efficiency ratio, and survival rate.
  • a basal feed(control group) was prepared to have energy content equal to 30% crude protein, as shown in Table 10.
  • the Bacillus sp. CJP-14 of the strain of the present invention was added to the basal feed to make mixed feed containing 5% Bacillus sp. CJP-14, and the amount of cellulose was reduced to the addition amount of probiotics for equal energy content.
  • the juvenile flounder used in the experiment had the initial average weight of 25 g, and 25 fish were randomly assigned to a 150 L round PP tank.
  • Sand-filtered seawater was used as culture water, and a flow rate was controlled to 2-3 L/min.
  • the tank was equipped with an air stone for oxygen supply and culture water circulation.
  • a photoperiod was maintained under the condition of 12L:12D using a fluorescent lamp.
  • the culture water temperature was maintained within the natural temperature conditions of 21-29°C during the entire experimental period.
  • the fish were fed to satiation twice a day.
  • the growth rate was measured every three weeks, and all fish were starved for 24 hours before measurement (see Table 11).
  • the addition of the Bacillus sp. CJP 14 increased the growth rate to approximately 13%, compared to the control group, and also increased the feed conversion ratio and protein efficiency ratio, compared to the control group.
  • the survival rate was also increased to approximately 25%, compared to the control group.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Husbandry (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Molecular Biology (AREA)
  • Insects & Arthropods (AREA)
  • Physiology (AREA)
  • Birds (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)

Abstract

La présente invention concerne des probiotiques pour la lutte biologique contre Saprolegnia sp., et en particulier une souche de bacille nouvellement isolée qui inhibe la croissance d'un champignon pathogène, Saprolegnia sp., et produit des sidérophores; un bouillon de culture obtenu par culture de cette souche, un concentré de celui-ci ou un produit sec de celui-ci; une composition probiotique, un additif pour l'alimentation animale, un agent antimicrobien, un agent antifongique ou un agent améliorant la qualité de l'eau comprenant ladite souche, ledit bouillon de culture, ledit concentré ou ledit produit sec; et un procédé de pisciculture ou de carcinoculture permettant de prévenir la saprolégniose chez les animaux et d'améliorer la qualité de l'eau au moyen de ladite souche, dudit bouillon de culture, dudit concentré ou dudit produit sec.
PCT/KR2012/000758 2011-01-31 2012-01-31 Probiotiques pour la lutte biologique contre saprolegnia sp. Ceased WO2012105804A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PH1/2013/501608A PH12013501608B1 (en) 2011-01-31 2012-01-31 Probiotics for biological control against saprolegnia sp.
RU2013138150/10A RU2555549C2 (ru) 2011-01-31 2012-01-31 ШТАММ Bacillus sp. ДЛЯ БИОЛОГИЧЕСКОЙ БОРЬБЫ С Saprolegnia sp. И ЕГО ПРИМЕНЕНИЯ

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2011-0009792 2011-01-31
KR1020110009792A KR101230813B1 (ko) 2011-01-31 2011-01-31 사프로레그니아 속 미생물에 대한 생물학적 방제용 프로바이오틱스

Publications (2)

Publication Number Publication Date
WO2012105804A2 true WO2012105804A2 (fr) 2012-08-09
WO2012105804A3 WO2012105804A3 (fr) 2012-12-20

Family

ID=46603210

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2012/000758 Ceased WO2012105804A2 (fr) 2011-01-31 2012-01-31 Probiotiques pour la lutte biologique contre saprolegnia sp.

Country Status (4)

Country Link
KR (1) KR101230813B1 (fr)
PH (1) PH12013501608B1 (fr)
RU (1) RU2555549C2 (fr)
WO (1) WO2012105804A2 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016147121A1 (fr) 2015-03-16 2016-09-22 Ecole Polytechnique Federale De Lausanne (Epfl) Archées dans des aliments pour animaux bioactifs, procédé de fabrication de la composition et procédés utilisant cette composition
CN110278704A (zh) * 2017-12-29 2019-09-24 Cj第一制糖株式会社 包括作为活性成分的枯草芽孢杆菌菌株、短小芽孢杆菌菌株和地衣芽孢杆菌菌株的用于预防或治疗急性肝胰腺坏死病(ahpnd)或白斑综合征(wss)的饲料组合物
CN115287328A (zh) * 2022-07-22 2022-11-04 集美大学 一种水产致病菌的潜在天然抗菌物质的筛选方法

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019132605A1 (fr) * 2017-12-29 2019-07-04 씨제이제일제당 (주) Composition d'aliment pour animaux contenant une souche de bacilius subtilus en tant que principe actif pour prévenir ou traiter une maladie de nécrose hépatopancréatique aiguë ou le syndrome des taches blanches
WO2019132600A1 (fr) * 2017-12-29 2019-07-04 씨제이제일제당 (주) Composition alimentaire contenant une souche bacilius subtilus, une souche bacilius pumilus et une souche bacilius lichenformis en tant que principes actifs pour prévenir ou traiter une maladie de nécrose hépatopancréatique aiguë ou un syndrome des taches blanches
KR102113974B1 (ko) * 2018-11-12 2020-05-20 경기도 아쿠아포닉스 전용 사료 및 그 제조방법
WO2020179999A1 (fr) 2019-03-07 2020-09-10 씨제이제일제당(주) Bacillus subtilis cjbs303 et composition le comprenant

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2081575C1 (ru) * 1995-07-26 1997-06-20 Тихоокеанский институт биоорганической химии Дальневосточного отделения РАН Способ профилактики заболевания икры и молоди рыб сапролегнией
DE10228627A1 (de) * 2002-06-26 2004-01-22 Biopract Gmbh Verfahren zur Prophylaxe und Therapie von Mykosen bei Fischen und Wirbellosen und deren Entwicklungsstadien
JP3713508B2 (ja) 2003-11-26 2005-11-09 株式会社九州メディカル バチルス・チューリンジェンシスの培養液を有効成分とする水産魚介類病原カビであるフサリウム菌に対する防除剤
WO2006101060A1 (fr) * 2005-03-22 2006-09-28 Kyushu Medical Co., Ltd. Procede de prevention des maladies fongiques des crustaces et des maladies fongiques des poissons en utilisant bacillus subtilis
KR101073791B1 (ko) * 2008-10-24 2011-10-13 전진바이오팜 주식회사 장내효소활성, 내산성, 내담즙성이 우수한 신규 락토바실러스 펜토서스 ｐｌ-11 균주와 이를 이용한 어류용 프로바이오틱스

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016147121A1 (fr) 2015-03-16 2016-09-22 Ecole Polytechnique Federale De Lausanne (Epfl) Archées dans des aliments pour animaux bioactifs, procédé de fabrication de la composition et procédés utilisant cette composition
CN110278704A (zh) * 2017-12-29 2019-09-24 Cj第一制糖株式会社 包括作为活性成分的枯草芽孢杆菌菌株、短小芽孢杆菌菌株和地衣芽孢杆菌菌株的用于预防或治疗急性肝胰腺坏死病(ahpnd)或白斑综合征(wss)的饲料组合物
CN110602950A (zh) * 2017-12-29 2019-12-20 Cj第一制糖株式会社 包括作为活性成分的枯草芽孢杆菌菌株的用于预防或治疗急性肝胰腺坏死病（ahpnd）或白斑综合征（wss）的饲料组合物
JP2020506872A (ja) * 2017-12-29 2020-03-05 シージェイ チェイルジェダン コーポレイション バチルス・サブチリス菌株を有効成分として含む急性肝膵臓壊死症（ａｈｐｎｄ）またはホワイトスポット病症候群（ｗｓｓ）の予防または治療用飼料組成物
EP3530123A4 (fr) * 2017-12-29 2020-08-19 CJ Cheiljedang Corporation Composition d'aliment pour animaux contenant une souche de bacilius subtilus en tant que principe actif pour prévenir ou traiter une maladie de nécrose hépatopancréatique aiguë ou le syndrome des taches blanches
EP3530124A4 (fr) * 2017-12-29 2020-10-21 CJ Cheiljedang Corporation Composition alimentaire contenant une souche bacilius subtilus, une souche bacilius pumilus et une souche bacilius lichenformis en tant que principes actifs pour prévenir ou traiter une maladie de nécrose hépatopancréatique aiguë ou un syndrome des taches blanches
TWI722358B (zh) * 2017-12-29 2021-03-21 南韓商Ｃｊ第一製糖股份有限公司 包括枯草桿菌菌株作為活性成分之用於預防或治療急性肝胰臟壞死病(ahpnd)或白斑綜合症(wss)之飼料組成物
AU2018395016B2 (en) * 2017-12-29 2021-04-15 Cj Cheiljedang Corporation Feed composition containing Bacilius subtilus strain, Bacilius pumilus strain, and Bacilius lichenformis strain as active ingredients for preventing or treating acute hepatopancreatic necrosis disease or white spot syndrome
JP2021098714A (ja) * 2017-12-29 2021-07-01 シージェイ チェイルジェダン コーポレイション バチルス・サブチリス菌株を有効成分として含む急性肝膵臓壊死症（ａｈｐｎｄ）またはホワイトスポット病症候群（ｗｓｓ）の予防または治療用飼料組成物
JP7036964B2 (ja) 2017-12-29 2022-03-15 シージェイ チェイルジェダン コーポレイション バチルス・サブチリス菌株を有効成分として含む急性肝膵臓壊死症（ａｈｐｎｄ）またはホワイトスポット病症候群（ｗｓｓ）の予防または治療用飼料組成物
US11432566B2 (en) 2017-12-29 2022-09-06 Cj Cheildejang Corporation Feed composition for preventing or treating acute hepatopancreatic necrosis disease (AHPND) or white spot syndrome (WSS), comprising a Bacillus subtilis strain, a Bacillus pumilus strain, and a Bacillus licheniformis strain as active ingredients
CN115287328A (zh) * 2022-07-22 2022-11-04 集美大学 一种水产致病菌的潜在天然抗菌物质的筛选方法

Also Published As

Publication number Publication date
RU2013138150A (ru) 2015-03-10
RU2555549C2 (ru) 2015-07-10
WO2012105804A3 (fr) 2012-12-20
KR101230813B1 (ko) 2013-02-06
PH12013501608B1 (en) 2019-02-20
KR20120088436A (ko) 2012-08-08
PH12013501608A1 (en) 2013-09-30

Similar Documents

Publication Publication Date Title
WO2012105805A2 (fr) Probiotiques pour la lutte biologique contre vibrio sp.
Soltani et al. Genus Bacillus, promising probiotics in aquaculture: aquatic animal origin, bio-active components, bioremediation and efficacy in fish and shellfish
US20190201458A1 (en) Microbial strains and their use in animals
WO2012105804A2 (fr) Probiotiques pour la lutte biologique contre saprolegnia sp.
WO2013151361A1 (fr) Nouveau bacillus subtilis
KR101370942B1 (ko) 신규 바실러스 서브틸리스
WO2020013669A1 (fr) Souche de lactobacillus plantarum cjlp475 ayant un effet antiviral et une efficacité immunorégulatrice et composition la comprenant
WO2019212299A1 (fr) Lactobacillus plantarum cjlp17 présentant une efficacité antivirale et immunomodulatrice et composition comprenant celle-ci
CN118715315A (zh) 具有改善的生长的芽孢杆菌门菌株
EP3676371A1 (fr) Nouvelle souche debacillus amyloliquefaciens
WO2015156509A1 (fr) Nouveau bactériophage et composition le contenant
WO2019045493A1 (fr) Nouvelle souche de bacillus amyloliquefaciens et procédé de préparation d'un produit de soja fermenté l'utilisant
WO2018030730A1 (fr) Lactobacillus salivarius cjls1511, composition d'additif alimentaire pour animaux comprenant la même bactérie ou des cellules mortes de celle-ci et procédé de production desdites cellules mortes
CN113412058B (zh) 含有产bacillaene的细菌的组合物或其制剂
WO2019160365A1 (fr) Procédé de production d'une composition fermentée ayant une odeur améliorée au moyen d'une levure
Bhatnagar et al. Influence of isolated Bacillus coagulans on growth performance and digestive enzyme activities of Catla catla
WO2020013670A1 (fr) Composition comprenant une souche cjlp475 de lactobacillus plantarum et une souche cjlp17 de lactobacillus plantarum et utilisation associée
US9352005B2 (en) Isolated-probiotics preparation containing Bacillus sp. strain
WO2020013672A1 (fr) Composition comprenant les souches cjlp475 de lactobacillus plantarum et cjlp243 de lactobacillus plantarum, et utilisation associée
KR102792000B1 (ko) 신규한 락토바실러스 루테리 psc102 균주 및 이의 용도
Akbar et al. Studies on probiotics administration and its influence on gut microflora of ornamental fish Brachydanio rerio larvae
WO2011055927A2 (fr) Composition constituée d'un mélange de microorganismes se développant dans des conditions super-acides et son utilisation
KR100445292B1 (ko) 다기능 프로바이오틱능력을 가지는 신규 엔테로코카스 페시움 유비티-엠01
Sumathi et al. Analysis of enzyme activities of the gut bacterial communities in Labeo rohita fed differentially treated animal fleshing diets
WO2013151363A1 (fr) Nouveau bacillus licheniformis séparé et probiotiques à l'aide de celui-ci

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12741526

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 12013501608

Country of ref document: PH

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 1301004267

Country of ref document: TH

ENP Entry into the national phase

Ref document number: 2013138150

Country of ref document: RU

Kind code of ref document: A

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC, F1205A DATED 18-11-2013

122 Ep: pct application non-entry in european phase

Ref document number: 12741526

Country of ref document: EP

Kind code of ref document: A2